EVALUATION OF ANTIBACTERIAL RESISTANCE OF BIOFILM FORMS OF AVIAN SALMONELLA GALLINARUM TO FLUOROQUINOLONES by Kamashi, Kumar et al.
  
 
Original Research Article 
EVALUATION OF ANTIBACTERIAL RESISTANCE OF BIOFILMFORMS OF 
AVIANSALMONELLA GALLINARUM TO FLUOROQUINOLONES 
 
ABSTRACT 
Antimicrobial resistance is a growing concern worldwide. The indiscriminate use of antibiotics 
for a period of time has led to the emergence of antibiotic resistance in pathogenic bacteria. The 
present study was designed to evaluate the antibacterial efficacy of fluoroquinolone drugs, 
ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin and ofloxacin 
against avian Salmonella gallinarumbacterial biofilms.The study parameters, minimum inhibitory 
concentration (MIC), minimum bactericidal concentration (MBC) and biofilm elimination 
concentration (BEC) were determined on days 1, 3, 7, 10, 14 and 20 post inoculation for the 
planktonic (free) and biofilm cells of S.gallinarumby macrobroth dilution method.The MIC and 
MBC values determined on days 1, 3, 7, 10, 14 and 20 for each of the fluoroquinolone drugs 
against the planktonic and biofilm forms of avian S.gallinarumwere found to be non-significant. 
BEC values determined against the biofilm forms of S.gallinarumduring the study period were 
found to be non-significant among the tested fluoroquinolones.The results of the present study 
demonstrated that fluoroquinolone drugs were effective in vitro against both the planktonic and 
biofilm forms of avian S.gallinarum. 
Keywords: antibiotic resistance, biofilm, biofilm elimination concentration (BEC), 
fluoroquinolones, minimum bactericidal concentration (MBC), minimum inhibitory concentration 
(MIC), S. gallinarum 
INTRODUCTION 
Antibacterial agents are commonly used as growth promoters in poultry and animal husbandry. 
Usage of antibiotics at sub therapeutic levels for therapeutic and prophylactic use can mediate 
the development of antimicrobial resistance in bacterial pathogens.Bacterial pathogens were 
gradually transformed to ‘biofilm forms’ and eventually more resistant to common antimicrobial 
drugs
1
. Under electron microscopy, biofilm revealed a pattern of colonization of bacterial cells in 
multiple layers
2, 3
. The bacterial cells bind firmly to the surface by producing exopolysaccharide 
glycocalyx polymers, forming a matrix inside which microcolonies develop.  As the size and 
number of the adherent microcolonies increases, they coalesce to form biofilms
4
. Bacterial 
biofilms are bacterial colonies adhering to a substrate, encased within the synthesized 
extracellular matrix of carbohydrate polysaccharide glycocalyx moiety
5
and thus protected from 
various antagonistic agents including antibiotics
6
.  
Fowl typhoid is a common infectious disease in poultry caused bySalmonella gallinarum. This 
dreadful disease produces persistent and recurrent morbidity and mortality in poultry. Poultry 
processing waste can act as reservoirs of transferrable drug-resistant Salmonella sp.
7
and 
contributed for the development of multiple drug resistance
8
. The virulence – associated plasmid 
of strains of S. gallinarumcontributes toward virulence in fowl typhoid
9
. 
Fluoroquinolones are synthetic antibacterial agents used in veterinary/ human medicine because 
of their high potency and rapid bactericidal action 
10, 11
. The target site for fluoroquinolones is the 
A subunit of DNA gyrase enzyme, which mediates the ATP-dependent crossing of one DNA 
duplex through a transient enzyme – bridge the double standard break in another DNA segment 
12, 13
. For E. coli and other Gram negative bacteria, the concentration of quinolone that inhibits 
supercoiling of plasmid DNA or DNA synthesis by 50 per cent correlates well with the MIC 
14, 
15, 16.   
  
 
Biofilm infections are of considerable importance in therapeutics. Since ciprofloxacin, a drug of 
the fluoroquinolone group, was effective in treating biofilm infections, the present study was 
carried out to evaluate the antibacterial efficacy of fluoroquinolone drugs against planktonic and 
biofilm forms of avian S. gallinarum. 
Materials and methods: 
The present study was carried out in Institute of Animal Health and Veterinary Biologicals, 
Hebbal, Bangalore, India.  
Culture 
The present study was conducted using Type I culture of S. gallinarumobtained from the 
Institute of Animal Health and Veterinary Biologicals (IAH&VB), Bangalore, India. Standard 




The fluoroquinolone drugs, ciprofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin 
and ofloxacinwere procured from Astrazeneca Pharmaceuticals Pvt. Ltd., Bangalore, India and 
enrofloxacin was obtained from Vetcare, Bangalore, India. 
Antimicrobial sensitivity test 
Antimicrobial susceptibility of S. gallinarumwas determined for the fluoroquinolone drugs, 
ciprofloxacin, enrofloxacin, moxifloxacin,sparfloxacin, norfloxacin, pefloxacin and ofloxacin by 
antimicrobial sensitivity test method
18
 using antimicrobial sensitivity test discs (Hi Media 
laboratories, Mumbai, India). 
Preparation of free form of S. gallinarum 
S. gallinarumculture grown in tryptic soya broth was harvested on days 1, 3, 7, 10, 14 and 20 
after inoculation.Free form of S. gallinarumwere then quantified by the Miles and Misra
19
 
method and expressed as colony-forming units per milliliter (CFU/ml). 
Preparation of biofilm form of S. gallinarum 
Growth medium  
To 0.16% tryptic soya broth, 0.3% w/v bentonite clay powder was added and mixed well. This 
medium was autoclaved and checked for sterility by incubating at 37C.  
Procedure  
To the biofilm growth medium, S. gallinaruminoculum containing 10
9
cells/ml was added and 
incubated at 37°C. The biofilm on the bentonite clay was harvested on days 1, 3, 7, 10, 14 and 20 
after inoculation. The biofilm cells were quantified by sedimenting the biofilm cells colonized on 
bentonite clay at 1000 rpm for 5 minutes. The bacterial biofilm sediment was retained and the 
supernatant was discarded. The pellet was washed thrice with phosphate buffered saline (pH 
7.4); later 10 ml. of sterile PBS was added to pellet and vortexed vigorously for 3 minutes. 
Biofilm cells released in supernatant were quantified by the Miles and Misra method
19
and 
expressed as colony forming unit (CFU/ml). Similarly, viable counts were determined on days 1, 
3, 7, 10, 14 and 20 post inoculation
20
. 
Estimation of minimum inhibitory concentration (MIC, g/ml) by macrobroth dilution 
method
21
for planktonic and biofilm cells of S. gallinarum 
 A two-fold serial dilution of fluoroquinolone antibacterial drug in tryptic soya broth was 
prepared.  One ml of planktonicS. gallinaruminoculum at a concentration of 10
6
CFU/ml was 
added to one ml of each dilution of fluoroquinolone drug preparation. Then the tubes were 
incubated at 37C for 18 to 24 hours.  Biofilm forms of S. gallinarumwere also processed in the 
same method. The MIC values were then noted as the least amount of antimicrobial drug that 
resulted in complete inhibition of growth of planktonic/biofilm cells ofS. gallinarum. The MIC 
  
 
values for planktonic and biofilm forms of S. gallinarumwere determined on days 1, 3, 7, 10, 14 
and 20 of post inoculation. 
Estimation of minimum bactericidal concentration (MBC, g/ml) by macrobroth dilution 
method
21
 for planktonicand biofilm cells of S. gallinarum 
 A two-fold serial dilution of fluoroquinolone drug in tryptic soya broth was prepared.  To one ml 
of each dilution of an antimicrobial preparation, one ml of planktonic/biofilm inoculum of S. 
gallinarumat a concentration of 10
6
 CFU/ml was added. The test tubes were then incubated at 
37C for 18 to 24 hours. After this inhibitory phase of the test was completed, 10µl from each 
tube was subcultured on a nutrient agar plate. The plates were then incubated overnight and the 
MBC was determined as the lowest concentration of antimicrobial agent, subculture of which 
was lethal to 99.9 per cent of the original inoculum. The MBCs for planktonic and biofilm forms 
of S. gallinarum were determined on days 1, 3, 7, 10, 14 and 20 of post inoculation.  
Estimation of biofilm elimination concentration (BEC, g/ml) for biofilm cells of S. 
gallinarum 
To one ml of S. gallinarumbiofilm inoculum containing 10
6
CFU/ml, one ml of each 
antimicrobial drug preparation prepared in tryptic soy broth (TSB) was added.  The tubes were 
incubated for 18 to 24 hours at 37C and at the end of the incubation period, each tube was 
vortex mixed for five minutes and 10l from each tube was dropped on to the surface of nutrient 
agar plate. The biofilm elimination concentration was the minimum amount of antibiotic 
concentration required to eliminate 99.9 per cent cells in the biofilms. The biofilm elimination 
concentrations were determined on days 1, 3, 7, 10, 14 and 20 of post inoculation. 
Statistical analysis  
The pairedt-test was used to assess the significance of the difference of two means whereas one-
way ANOVA was employed to compare all the groups. The values were expressed as mean + 
SE, n= 6. The computer software Graph Pad Prism version IV was used to analyze the data. 
RESULTS 
Antimicrobial sensitivity test 
In the present study, the antimicrobial sensitivity test revealed that S. gallinarumwas found to be 
sensitive to all the fluoroquinolone drugs tested such as ciprofloxacin, enrofloxacin, 
moxifloxacin, sparfloxacin, norfloxacin, pefloxacin, and ofloxacin. The results were represented 
in Table 1. 
Minimum inhibitory concentration (MIC, g/ml) 
The minimum inhibitory concentrations of ciprofloxacin, enrofloxacin, moxifloxacin, 
sparfloxacin, norfloxacin, pefloxacin, and ofloxacin for the planktonic and biofilm forms of       
S. gallinarumdetermined on days 1, 3, 7, 10, 14 and 20 were compared by paired t-test. On 
analysis, the MIC values for planktonic forms of S. gallinarumrevealed no significant difference 
(P>0.05) with the MIC values of biofilm forms. Also the MIC values of planktonic and biofilm 
forms of S. gallinarumshowed no significant difference among the fluorquinolone drugs tested. 
The MIC values of planktonic and biofilm forms of S. gallinarumagainst the tested 
fluoroquinolones during the period of 20 days are collectively presented in Figures1 and 2 
respectively. 
 
Minimum bactericidal concentration (MBC, g/ml) 
The minimum bactericidal concentrations of ciprofloxacin, enrofloxacin, moxifloxacin, 
sparfloxacin, norfloxacin, pefloxacin, and ofloxacin for the planktonic and biofilm forms of S. 
gallinarumdetermined respectively on days 1, 3, 7, 10, 14 and 20 were found to be non-
significant. The data presented in Figures3 and 4 depicted the MBC values of each 
  
 
fluoroquinolone drug determinedon specific days for planktonic and biofilm forms of S. 
gallinarumanddid not differ significantly (P>0.05) among the fluoroquinolone drugs. In this 
study, MBC values of the fluoroquinolone drugs tested were found to be higher than their 
corresponding MIC values. 
Biofilm elimination concentration (BEC, g/ml) 
The BEC values of ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, 
pefloxacin, and ofloxacin for the biofilm forms of S. gallinarumare presented in Figure 5. The 
BEC values determined on days 1, 3, 7, 10, 14 and 20 were found to be non-significant (P>0.05) 
among the tested fluoroquinolone drugs. Also, BEC values were found to be higher than their 
respective MBC values. 
DISCUSSION 
Antimicrobial resistance development in bacterial organisms could be associated mainly with 
injudicious use of the antibiotics for therapeutic purposes. This would be expressed as poor 
permeation of antibacterial drugs to the target site or rapid drug inactivation or the modification 
of target drug site. The antibacterial resistance could be either intrinsic or acquired through 
plasmids. Additional ways of resisting the actions of antibacterial agents by bacteria is by 
formation of biofilms.   
In the present study, avian S. gallinarumwas found to be sensitive for the fluoroquinolone drugs 
tested, such as ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin, 
and ofloxacin, using the antimicrobial sensitivity test. This could be attributed to the higher 
lipophilic nature of fluoroquinolones so that the drug can easily enter the bacterial cells and 
binds with higher affinity to topoisomerase targets 
22, 23
. These findings were in accordance with 
similar research studies 
24, 25, 26, 27
. 
In this study, the MIC (g/ml) of the tested fluoroquinolone drugs revealed no difference 
(P>0.05) for the inhibition of planktonic cell form and biofilm cell forms of S. gallinarum, 
whereas MIC of norfloxacin and pefloxacin on Day 3 and 7, respectively were higher against the 
biofilm cells as compared to MIC for planktonic cells. This might be due to the complexity of 
biofilm structure
1
 requiring a higher drug concentration of these drugs for the inhibition of 
bacterial growth. The comparison of MICs for ciprofloxacin, enrofloxacin, moxifloxacin, 
sparfloxacin, norfloxacin, pefloxacin and ofloxacin against the planktonic and biofilm cells of S. 
gallinarum revealed that all drugs were effective in inhibiting the planktonic and biofilm forms. 
This could be attributed to the better penetrating ability of fluoroquinolones through the biofilm 
via the bacterial pores or channels 
23, 28
. 
The MBC (g/ml) of the tested fluoroquinolone drugs revealed no difference (P>0.05) for the 
inhibition of planktonic cell form and biofilm cell forms, whereas MBC of pefloxacin and 
ofloxacin on Day 10 and 20, respectively was higher against the biofilm cells as compared to 
MIC for planktonic cells. This could be due to the complexity of biofilm structure
1
or any 
changes in CFU/ ml of the bacterial organisms. The results were in accordance to the reports 
where enrofloxacin and ciprofloxacin, respectively was found to be effective against the 
planktonic cell forms and the biofilm cell forms of S. gallinarum
27, 29
. 
The biofilms are colonisation of bacterial organisms.  The surface pores or channels of bacteria 
penetrate through the biofilms, so forming the pathway of antibiotic penetration
30
. Since, 
fluoroquinolones are meant for their good penetrating ability, these drugs can enter through the 
biofilms and reach the target site of drug action. 
The biofilm elimination concentration of the tested fluoroquinolone drugs for the biofilm cells of 
S. gallinarum revealed no difference (P>0.05) among each other. The BEC of fluoroquinolone 
drugs were higher than MBCs observed. The reason might be due to the production of an 
  
 
exopolysaccharide matrix or glycocalyx by biofilms, which prevents the access of antibiotics to 
the bacterial cells embedded in biofilm 
1, 31
. 
The minimum inhibitory concentration (MIC, µg/ml) and minimum bactericidal concentration 
(MBC, µg/ml) of ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, 
pefloxacin and ofloxacin revealed no significant difference (P>0.05) for the inhibition of 
planktonic cells and biofilm cells during the study period. This indicates that all the 
fluoroquinolone drugs tested were effective in inhibiting both the planktonic and biofilm cells. 
This could be attributed to the ability of fluoroquinolones to penetrate biofilm via the bacterial 
pores or channels 
23, 28
. Confocal scanning laser microscopy studies demonstrated pores/channels 
permeating through the bacterial biofilms
30
. It could be hypothesized that the fluoroquinolones 
can penetrate through these bacterial pores in the biofilms to reach the target site of action. This 
could be further correlated to the reportwherein ciprofloxacin can effectively induced 
detachment in biofilm cells for drug penetration
28
. The results of the present study were in 
accordance with the reports where enrofloxacin and ciprofloxacin were found to be effective 
against the planktonic and the biofilm cell forms of E. coli
27, 29
.  
In the present study, the BEC values obtained were higher than the MBCs observed for the 
individual drugs. This might be possibly due to the additional factors contributing for the 
increased resistance of biofilms such as the complex structure of the bacterial biofilms, lower 
penetration of antibacterial agents into biofilm, growth rate of bacteria in biofilm forms and 
altered gene expression in biofilms
1
. Bacterial biofilms are composed of several layers and act as 
a barrier for the antimicrobial penetration. This might have increased the resistance for the 
elimination of biofilms at normal MBC
 32
; hence the BEC values for the fluoroquinolone drugs 
tested would be higher.  Moreover, the extracellular matrix of biofilms is negatively charged, the 
interaction of drug molecules with such a negatively charged matrix could also be a contributing 




From this study, it could be concluded that fluoroquinolone antibacterial agents, ciprofloxacin, 
enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin, and ofloxacin were effective 
in vitroagainst the planktonic and biofilm forms of avian S. gallinarum. These research findings 
should be further applied in vivo to determine the efficacy of fluoroquinolones in treating 
chronic/biofilm related infections. 
Acknowledgements: 
The authors thank the Dean, Veterinary College, University of Agricultural Sciences, Hebbal, 
Bangalore, India for providing assistance during the study period. Special memorable thanks to  
the former Director, Late Dr. G. Krishnappa, Institute of Animal Health and Sciences 
(IAH&VB), Hebbal, Bangalore, India for his encouragement, guidance and for providing the 
necessary facilities for carrying out this research. A special thanks to the Scientists and technical 
staffs of IAH&VB for offering technical services to carry out the research in IAH&VB. 
Complimentary samples of drugs were provided by Astrazeneca Pharmaceuticals, Bangalore and 
Vetcare, Bangalore, India.  
CONFLICT OF INTEREST: 
No conflict of interest associated with this work. 
References 
1. Thien-Fah C, O’Toole GA. Mechanism of biofilm resistance to antimicrobial 
agents,Trends Microbiol. 2001; 9:34-39. 
2. Nickel JC, Heaton J, Morales A, Costerton JW. Bacterial biofilm in persistent penile 
prosthesis – associated infection, J Urol. 1986;135:586-588. 
  
 
3. Costerton JW. Structure and plasticity at various organization levels in the bacterial cell,  
Can J Microbiol. 1988;34:513-521. 
4. Loosdrecht, M.C.M.V., Lyklema, J., Norde, W. and Zehnder. Influence of interfaces on 
microbial activity,Microbiol. Rev. 1990;54: 75-87. 
5. Wilson M. Bacterial biofilms and human disease. Sci. Progress 2001;84:235-254. 
6. Wimpenny, J.W.T. and Kinniment, S.L. Measurement of the contribution of adenylate 
concentrations and adenylate charge across Pseudomonas aeruginosa biofilms,Appl. 
Environ. Microbiol.1992;58: 1629-1635. 
7. Goyal, S.M. and Hoodley, A.W. Salmonellae and their associated R-plasmids in poultry 
processing wastes,Revista-de-Microbiologia-Brazil, 1979; 10: 50-58. 
8. Anjanappa, M., Harbola, P.C. and Verma, J.C.  Plasma profile analysis of field strains of 
Salmonella gallinarum, Indian Vet J. 1994; 71: 417-421. 
9. Barrow, P.A., Simpson, J.M., Lovell, M.A. and Binns, M.M.  Contribution of Salmonella 
gallinarum large plasmid toward virulence in fowl typhoid,Inf. Immunity, 1987; 55:388-
392. 
10. Brown, S.A. Fluoroquinolones in animal health,J. Vet. Pharmacol. Therapy,1996; 19: 1-
14. 
11. Sanders, C.C. Ciprofloxacin: in vitro activity, mechanism of action and resistance.  Rev. 
Infect. Dis.,1988;10:516-527. 
12. Mizuuchi, K., Fisher, L.M., O’Dea, M.H. and Gellert, M. DNA gyrase action involves 
the introduction of transient double standard breaks into DNA, Proc. Natl. Acad. Sci., 
USA, 1980; 77:1847-1851. 
13. Kato, J., Nishimura, Y., Imamura, R., Niki, H., Higara, S. and Suzuki, H.New 
topoisomerase essential for chromosome segregation in E. coli,Cell,1990; 63: 393-104. 
14. Domagala, J.M., Hanna, L.D., Heifitz, C.L., Hutt, M.P., Sanchez, J.P. and Solomon, M.  
New structure activity relationships of the quinolone antibacterials using the target 
enzyme.  The development and application of a DNA gyrase assay,J. Med. Chem.1986; 
29: 394-404. 
15. Chow, R.T., Dougherty, T.J., Fraimow, H.S., Bellin, E.Y. and Miller, M.H.  Association 
between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone 
antimicrobial agents for wild-type and mutant [gyrAnfxB (ompF) acrA] Escherichia coli 
K-12. Antimicrob. Agents Chemother. 1988; 32: 1113-1118. 
16. Piddock, L.J.V., Walters, R.N. and Diver, J.M. Correlation of quinolone MIC and 
inhibition of DNA, RNA and protein synthesis and induction of the SOS response in 
Escherichia coli. Antimicrob. Agents Chemother.,1990;34: 2331-2336. 
17. Cruickshank, R., Duguid, J.P., Marimion, B.P. and Swain, R.H.A.In: Medical 
Microbiology, 12
th
Edn.,1975, Churchill Livingstone, Edinburgh, London. 
18. Bauer, A.W., Kirby, W.M.M., Sherris, J.S. and Turkek, M. Antibiotic susceptibility 
testing by a standardised method.  Am J. Clin. Pathol.1966; 45: 493-496. 
19. Miles, A.A. and Misra, S.S. The bactericidal power of blood.  J. Hyg. 1938;38: 732. 
20. Shivaraj D. Biofilm production of Escherichia coli and Salmonella gallinarum and 
evaluation of oral Escherichia coli vaccines in chicks.  M.V.Sc. Thesis; UnivAgri Sci., 
Bangalore, India, 1998. 
21. Matsen JM. Bacterial susceptibility testing and assays.  In: Clinical Diagnosis 
andManagement by Laboratory Methods. Ed. Henry JC, 17
th
Edn. 1989, W.B. Saunders 
Co., Philadelphia, pp. 1322-1352. 
22. Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones.  
Clin. Infect. Dis. 2000;31:S24-S28. 
23. Muller M, Stab H, Brunner M, Moller JG, Lackner E, Eichler HG.  Penetration of 
moxifloxacin into peripheral compartments in humans. Antimicrob. Agents Chemother. 
1999;43:2345-2349. 
24. Tang HJ, Chang MC, Ko WC, Huang KY, Lee CL, Chuang YC. In vitro and in vivo 




25. Wright DH, Gunderson B., Hovde LB, Ross GH, Ibrahim KH, Rotschafer JC.   
Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of 
Staphylococci in an in vitro model under aerobic and anaerobic conditions. Antimicrob. 
Agents Chemother. 2002;46:1561-1563. 
26. Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effect of 
fluoroquinolones for the eradication of nontypeableHaemophilusinfluenzae isolates 
within biofilms. Tohoku J Exp Med. 2008;214 (2):121-8. 
27. Ramesh N. Studies on resistance to antibacterial agents with reference to the plasmid 
profile and biofilm formation in certain poultry pathogens.  Ph.D. Thesis,2003; Univ.Agri 
Sci., Bangalore, India. 
28. Suci PA, Mittelman MW, Yu FP, Geesey GG. Investigation of ciprofloxacin penetration 
into Pseudomonas aeruginosa biofilms.  Antimicrob. Agents Chemother. 1994;38: 2125-
2133. 
29. Olson ME, Ceri H, Morck DW, Buret AG, Read PR. Biofilm bacteria: formation and 
comparative susceptibility to antibiotics.  Can J Vet Res. 2002;66:86-92. 
30. DeBeer D, Stoodley P, Roe F, Lewandowski Z. Oxygen distribution and mass transport 
in biofilms.  BiotechnolBioengg. 1993;43:1131-1138. 
31. Stewart, P.S.Theoretical aspects of antibiotic diffusion into microbial 
biofilms.Antimicrob. Agents Chemother.1996; 40: 2517-2522. 
32. Christensen BB, Sternberg C, Andersen JB, Molin OS.  In situ detection of gene transfer 





Table 1.  Antimicrobial sensitivity test of S. gallinarum 
Sl. No. Antimicrobial disc Disc content (g) 
Diameter of zone of 
inhibition (mm)* 
1 Ciprofloxacin 5 23 
2 Enrofloxacin 5 22 
3 Moxifloxacin 5 21 
4 Sparfloxacin 5 21 
5 Norfloxacin 10 19 
6 Pefloxacin 5 17 
7 Ofloxacin 5 18 













Figure 1.Comparison of the minimum inhibitory concentration (MIC, g/ml) 
ofciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin 






























Figure 1. Comparison of the minimum inhibitory concentration (MIC, µg/ml) 
of ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, 
pefloxacin and ofloxacin for planktonic cells of S. gallinarum 
Ciprofloxacin Enrofloxacin Moxifloxacin Sparfloxacin 
Norfloxcain Pefloxacin Ofloxacin 
  
 
Figure2. Comparison of the minimum inhibitory concentration (MIC, g/ml) of 
ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin 

































Figure 2. Comparison of the minimum inhibitory concentration (MIC, µg/ml) 
of ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, 
pefloxacin and ofloxacin for biofilm cells of S. gallinarum 
Ciprofloxacin Enrofloxacin Moxifloxacin Sparfloxacin 
Norfloxcain Pefloxacin Ofloxacin 
  
 
Figure 3. Comparison of the minimum bactericidal concentration (MBC, g/ml) of 
ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin 































Figure 3. Comparison of the minimum bactericidal concentration (MBC, µg/ml)   
of ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, 
pefloxacin and ofloxacin for planktonic cells of S. gallinarum                                   
Ciprofloxacin Enrofloxacin Moxifloxacin Sparfloxacin 
Norfloxcain Pefloxacin Ofloxacin 
  
 
Figure 4. Comparison of the minimum bactericidal concentration (MBC,g/ml) of 
ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin 
































Figure 4. Comparison of the minimum bactericidal concentration (MBC, 
µg/ml) of ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, 
norfloxacin, pefloxacin and ofloxacin for biofilm cells of S. gallinarum 
Ciprofloxacin Enrofloxacin Moxifloxacin Sparfloxacin 
Norfloxcain Pefloxacin Ofloxacin 
  
 
Figure 5. Comparison of the biofilm elimination concentration (BEC,g/ml) of 
ciprofloxacin, enrofloxacin, moxifloxacin, sparfloxacin, norfloxacin, pefloxacin 





















Figure 5. Comparison of biofilm elimination concentration (BEC, µg/ml) 
Ciprofloxacin, Enrofloxacin, Moxifloxacin, Sparfloxacin, Norfloxacin, Pefloxacin 
and  Ofloxacin for biofilm cells of S. gallinarum 
Ciprofloxacin Enrofloxacin Moxifloxacin Sparfloxacin 
Norfloxacin Pefloxacin Ofloxacin 
